Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2022 Jan 14;14(2):342.
doi: 10.3390/nu14020342.

The Impact of Selenium Supplementation on Trauma Patients-Systematic Review and Meta-Analysis

Affiliations
Meta-Analysis

The Impact of Selenium Supplementation on Trauma Patients-Systematic Review and Meta-Analysis

Jen-Fu Huang et al. Nutrients. .

Abstract

This study aimed to assess current evidence regarding the effect of selenium (Se) supplementation on the prognosis in patients sustaining trauma. MEDLINE, Embase, and Web of Science databases were searched with the following terms: "trace element", "selenium", "copper", "zinc", "injury", and "trauma". Seven studies were included in the meta-analysis. The pooled results showed that Se supplementation was associated with a lower mortality rate (OR 0.733, 95% CI: 0.586, 0.918, p = 0.007; heterogeneity, I2 = 0%). Regarding the incidence of infectious complications, there was no statistically significant benefit after analyzing the four studies (OR 0.942, 95% CI: 0.695, 1.277, p = 0.702; heterogeneity, I2 = 14.343%). The patients with Se supplementation had a reduced ICU length of stay (standard difference in means (SMD): -0.324, 95% CI: -0.382, -0.265, p < 0.001; heterogeneity, I2 = 0%) and lesser hospital length of stay (SMD: -0.243, 95% CI: -0.474, -0.012, p < 0.001; heterogeneity, I2 = 45.496%). Se supplementation after trauma confers positive effects in decreasing the mortality and length of ICU and hospital stay.

Keywords: injury; selenium; trace element; trauma.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Figures

Figure 1
Figure 1
Protocol of this systematic review.
Figure 2
Figure 2
Forest chart of selenium (Se) supplementation on mortality of severe trauma patients.
Figure 3
Figure 3
Forest chart of selenium (Se) supplementation on infection occurrence in severe trauma patients.
Figure 4
Figure 4
Forest chart of selenium (Se) supplementation on the length of intensive care unit stay of severe trauma patients.
Figure 5
Figure 5
Forest chart of selenium (Se) supplementation on the length of hospital stay of severe trauma patients.

References

    1. Demetriades D., Kimbrell B., Salim A., Velmahos G., Rhee P., Preston C., Gruzinski G., Chan L. Trauma Deaths in a Mature Urban Trauma System: Is “Trimodal” Distribution a Valid Concept? J. Am. Coll. Surg. 2005;201:343–348. doi: 10.1016/j.jamcollsurg.2005.05.003. - DOI - PubMed
    1. Sobrino J., Shafi S. Timing and Causes of Death after Injuries. Bayl. Univ. Med. Cent. Proc. 2013;26:120–123. doi: 10.1080/08998280.2013.11928934. - DOI - PMC - PubMed
    1. Gunst M., Ghaemmaghami V., Gruszecki A., Urban J., Frankel H., Shafi S. Changing Epidemiology of Trauma Deaths Leads to a Bimodal Distribution. Bayl. Univ. Med. Cent. Proc. 2010;23:349–354. doi: 10.1080/08998280.2010.11928649. - DOI - PMC - PubMed
    1. Ciesla D.J., Moore E.E., Johnson J.L., Burch J.M., Cothren C.C., Sauaia A. A 12-Year Prospective Study of Postinjury Multiple Organ Failure: Has Anything Changed? Arch. Surg. 2005;140:432–438. doi: 10.1001/archsurg.140.5.432. discussion 438–40. - DOI - PubMed
    1. Lord J.M., Midwinter M.J., Chen Y.-F., Belli A., Brohi K., Kovacs E.J., Koenderman L., Kubes P., Lilford R.J. The Systemic Immune Response to Trauma: An Overview of Pathophysiology and Treatment. Lancet. 2014;384:1455–1465. doi: 10.1016/S0140-6736(14)60687-5. - DOI - PMC - PubMed